Nine Chapters Capital Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Nine Chapters Capital Management’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$38K	Buy	+185	New	+$34K	0.08%	142
2015 Q3	–	Sell	-30	Closed	-$84K	–	1203
2015 Q2	$84K	Sell	30 -7	-19%	-$29.5K	0.01%	884
2015 Q1	$198K	Buy	37 +10	+37%	+$57.3K	0.02%	833
2014 Q4	$165K	Buy	27 +20	+286%	+$168K	0.01%	819
2014 Q3	$88K	Buy	7 +6	+600%	+$76.9K	0.01%	935
2014 Q2	$12K	Buy	+1	New	+$11.2K	﹤0.01%	918

Other funds holding CSCI

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Nine Chapters Capital Management's CSCI Position: Q3 2017 in Review

Nine Chapters Capital Management opened a new position in COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2017: 185 shares worth $38K. The stake represents 0.08% of the portfolio and ranks #142 among its holdings. This is a return to the name: Nine Chapters Capital Management previously reported a position in CSCI as recently as Q2 2015.

Nine Chapters Capital Management first reported a position in CSCI in Q2 2014 and has held it in 6 quarters since. The position peaked at $198K in Q1 2015. 18 funds tracked by Wall St. Rank hold CSCI as of Q3 2017.

Nine Chapters Capital Management held 185 shares of COSCIENS Biopharma Inc. Common Stock worth $38K as of Q3 2017.
COSCIENS Biopharma Inc. Common Stock was a new Nine Chapters Capital Management position in Q3 2017.
COSCIENS Biopharma Inc. Common Stock made up 0.08% of Nine Chapters Capital Management's portfolio in Q3 2017, its #142 holding.
Nine Chapters Capital Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2014 and has held it in 6 quarters since.
Nine Chapters Capital Management's COSCIENS Biopharma Inc. Common Stock position peaked at $198K in Q1 2015.
18 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2017.

Based on Nine Chapters Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.